HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulation of the low pathogenic avian influenza subtype H5N2 virus in ducks at a live bird market in Ibadan, Nigeria.

AbstractBACKGROUND:
To monitor carrier hosts of avian influenza in Nigeria, we randomly collected cloaca swab specimens from 155 ducks at a live bird market (LBM) in Ibadan, southwest Nigeria, between July 2011 and July 2012.
METHODS:
The samples were analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and virus isolation was carried out in embryonated chicken eggs. Partial sequencing of the antigenic cleavage site of the haemagglutinin (HA) gene was performed, multiple sequence alignment was carried out using ClustalW, and a phylogenetic tree was constructed using the neighbor joining method.
RESULTS:
Twenty (13%) of the 155 samples were positive for avian influenza subtype H5N2 by real-time RT-PCR and three isolates were obtained from embryonated chicken eggs. Partial sequencing of the amino acid cleavage site of the HA genes of two isolates corresponded to a PQRETGL*F sequence that is common in low pathogenic avian influenza (LPAI). Phylogenetically, the HA genes of the two influenza viruses are monophyletic and clustered with H5N2 viruses detected in wild ducks from Africa.
CONCLUSION:
The occurrence of LPAI in domestic ducks in Nigeria underscores the importance of continuous surveillance and monitoring of the virus (in a country that is considered to be free of avian influenza) in order to prevent the emergence of virulent strains that may spread to commercial poultry and humans.
AuthorsTemitope Coker, Clement Meseko, Georgina Odaibo, David Olaleye
JournalInfectious diseases of poverty (Infect Dis Poverty) Vol. 3 Issue 1 Pg. 38 ( 2014) ISSN: 2095-5162 [Print] England
PMID25671118 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: